# A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

> **NCT01269216** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 136 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** 5-FU with leucovorin
- **DRUG:** TS-1 with Irinotecan

## Key facts

- **NCT ID:** NCT01269216
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269216, "A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01269216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*